The 11% Return This Week Takes Jiangsu Huifeng Bio Agriculture's (SZSE:002496) Shareholders One-year Gains to 28%
The 11% Return This Week Takes Jiangsu Huifeng Bio Agriculture's (SZSE:002496) Shareholders One-year Gains to 28%
The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you could make more than that. For example, the Jiangsu Huifeng Bio Agriculture Co., Ltd. (SZSE:002496) share price is up 28% in the last 1 year, clearly besting the market return of around 8.9% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! Unfortunately the longer term returns are not so good, with the stock falling 11% in the last three years.
投資股票的最簡單方式是購買交易所交易基金。但如果你選擇了合適的個股,你可能會獲得更多的回報。例如,輝豐股份(SZSE:002496)的股價在過去一年上漲了28%,明顯超過市場回報的約8.9%(不包括分紅派息)。如果它能夠在開多的情況下保持這種表現,投資者將會獲得很好的回報! 不幸的是,長期回報並不好,過去三年股票下跌了11%。
On the back of a solid 7-day performance, let's check what role the company's fundamentals have played in driving long term shareholder returns.
在穩定的七天表現之後,讓我們看看公司的基本面對長期股東回報的影響。
Given that Jiangsu Huifeng Bio Agriculture didn't make a profit in the last twelve months, we'll focus on revenue growth to form a quick view of its business development. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.
鑑於輝豐股份在過去十二個月沒有盈利,我們將重點關注營業收入的增長,以便快速了解其業務發展。一般來說,沒有利潤的公司期望每年都能增長營業收入,並且增長速度較快。這是因爲快速的營業收入增長可以很容易地推測未來的利潤,通常是相當可觀的。
Jiangsu Huifeng Bio Agriculture actually shrunk its revenue over the last year, with a reduction of 0.7%. Despite the lack of revenue growth, the stock has returned a solid 28% the last twelve months. To us that means that there isn't a lot of correlation between the past revenue performance and the share price, but a closer look at analyst forecasts and the bottom line may well explain a lot.
輝豐股份實際上在過去一年中營業收入減少了0.7%。儘管缺乏營業收入增長,該股票在過去十二個月的回報依然達到28%。這對我們來說意味着,過去的營業收入表現與股價之間的相關性並不大,但是更深入地看分析師的預測和底線可能會解釋很多。
You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).
您可以看到以下收益和營收的變化情況(通過單擊圖像了解精確值)。

If you are thinking of buying or selling Jiangsu Huifeng Bio Agriculture stock, you should check out this FREE detailed report on its balance sheet.
如果你在考慮買入或賣出輝豐股份的股票,你應該查看這份關於其資產負債表的免費詳細報告。
A Different Perspective
另一種看法
It's nice to see that Jiangsu Huifeng Bio Agriculture shareholders have received a total shareholder return of 28% over the last year. Notably the five-year annualised TSR loss of 2% per year compares very unfavourably with the recent share price performance. We generally put more weight on the long term performance over the short term, but the recent improvement could hint at a (positive) inflection point within the business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for Jiangsu Huifeng Bio Agriculture you should know about.
很高興看到輝豐股份的股東在過去一年中獲得了28%的總股東回報。值得注意的是,五年年化TSR每年損失2%與近期的股價表現相比非常不利。我們通常更看重長期表現而非短期表現,但近期的改善可能暗示着業務中的一個(積極的)拐點。雖然考慮市場條件對股價的不同影響是很值得的,但還有其他因素更爲重要。例如,考慮風險。每家公司都有風險,而我們發現輝豐股份有2個警示信號你應該知道。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.
如果您願意查看另一家公司(具有潛在的更好財務狀況),請不要錯過這個免費的公司列表,證明它們可以增長收益。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文中引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。